Skip to content

Military to Civilian: Trial of an Intervention to Promote Postdeployment Reintegration

Military to Civilian: RCT of an Intervention to Promote Postdeployment Reintegration

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00640445
Acronym
M2C
Enrollment
1292
Registered
2008-03-21
Start date
2011-06-30
Completion date
2013-09-30
Last updated
2015-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Posttraumatic Stress Disorder

Keywords

Clinical Trial, Combat Disorders, PTSD, Internet-Based Intervention, Mental Health Services, Post-deployment Reintegration

Brief summary

Veterans returning from combat deployments face the interrelated challenges of processing their combat experiences and transitioning back to civilian life. Unfortunately, many veterans wait years or decades before seeking help for post-deployment problems, if they seek it at all. This study seeks to determine whether Internet-Based Expressive Writing (IB-EW), a brief, low-cost, easily disseminated, and resource-efficient intervention, can reduce psychological symptoms and improve functioning among Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF) veterans as they navigate this transition, while also attempting to reduce barriers to help-seeking. Expressive Writing, a highly private, readily accessible, and non-stigmatizing intervention, has a strong evidence-base in civilian populations, but its efficacy in combat veterans has not been tested. This study therefore seeks to test the efficacy of Expressive Writing in a veteran population while further enhancing its accessibility by delivering it over the internet (Internet-Based Expressive Writing; IB-EW). This study will comprise a randomized controlled trial with three conditions: (a) Internet-Based Expressive Writing, (b) Internet-Based Control Writing, and (c) No Writing/Treatment As Usual, with a total of 1152 OIF/OEF veterans randomized across these groups. Expressive Writing participants will write with feeling about their transition from being a soldier to being a civilian; Control Writing participants will write factually about the information needs of new veterans; and Treatment as Usual participants will complete the assessments but not engage in any writing assignments. Participants will complete standardized self-report measures of psychological symptoms, psychosocial functioning, and life satisfaction at baseline (Session 1) and at three months (Session 6) and six months (Session 7) post-intervention. Participants in writing conditions will write for 20 minutes on four consecutive days (Sessions 2-5) following completion of baseline measures (participants in the TAU condition will not complete Sessions 2-5). The study will also attempt to identify individual difference characteristics related to the efficacy of the treatment, to see who may be most likely to benefit from the treatment. Analyses will primarily entail multivariate analyses of variance. Power is adequate to detect even a small effect.

Interventions

BEHAVIORALExpressive Writing

In EW, people are asked to write about their deepest thoughts and feelings surrounding a significant life event for 20 minutes a day for 4 days

BEHAVIORALControl Writing

Those assigned to control writing conditions are asked to describe factual information for 20 minutes a day for 4 days.

Sponsors

United States Department of Defense
CollaboratorFED
US Department of Veterans Affairs
CollaboratorFED
Minneapolis Veterans Affairs Medical Center
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Veteran from current wars in Iraq and Afghanistan * At least a little difficulty transitioning from soldier to civilian * Access to computer with internet * Provide valid contact information * Available to participate for up to 40 minutes per session * Interested in participation * Understand procedures and consent * Note: participants are recruited by random selection from the target population

Exclusion criteria

* Severe depression

Design outcomes

Primary

MeasureTime frame
Life satisfactionBaseline, 3-month, 6-month
Reintegration difficultyBaseline, 3-month, 6-month
Social supportBaseline, 3-month, 6-month
PTSD symptomsBaseline, 3-month, 6-month
HostilityBaseline, 3-month, 6-month
Psychological distressBaseline, 3-month, 6-month
Physical symptomsBaseline, 3-month, 6-month

Secondary

MeasureTime frame
Employment statusBaseline, 3-month, 6-month
Emotion and causal word use in participants' essaysIntervention Sessions (up to 4 sessions post-baseline for participants assigned to a writing condition)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026